Cargando…
When Autoimmunity ‘DRESSes up’: A Case after Certolizumab Therapy
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is characterised by skin rash together with visceral organ involvement, lymphadenopathy, eosinophilia and atypical lymphocytosis. The syndrome is clinically heterogeneous, making diagnosis challenging. It has an annual incidence of 2 per...
Autores principales: | Marigliano, Benedetta, Rosa, Federico, Internullo, Mattia, Scuro, Luigi, Tavanti, Andrea, Del Vecchio, Lucia Rita, Romagno, Francesco Paolo, Schito, Maria Barbara, Pace, Federica, Colombo, Giovanni Maria, Guglielmelli, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426962/ https://www.ncbi.nlm.nih.gov/pubmed/36051169 http://dx.doi.org/10.12890/2022_003451 |
Ejemplares similares
-
New biologics in the management of Crohn’s disease: focus on certolizumab pegol
por: Colombo, Elisabetta, et al.
Publicado: (2009) -
Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022) -
Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
por: Lee, Jee Un, et al.
Publicado: (2017) -
Profile of certolizumab and its potential in the treatment of psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2013) -
5. Certolizumab Pegol for RA in pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)